患有复发性胰腺腺癌的患者的预后因素
Tatsuaki Sumiyoshi1, Kenichiro Uemura2, Ryuta Shintakuya1
1Department of Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551, Japan.
Langenbeck's archives of surgery
|September 2, 2023
概括
红细胞输血,低蛋白和高碳水化合物抗原19-9水平是胰腺癌复发患者生存时间缩短的关键预测因素. 这些因素显著影响胰腺管道腺癌 (PDAC) 复发后的结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 临床医学 临床医学
背景情况:
- 胰腺管腺癌 (PDAC) 是一种具有不良预后的侵袭性恶性瘤.
- 确定复发后生存的预后因素对于患者管理至关重要.
研究的目的:
- 确定影响PDAC患者复发后生存的独立预后因素.
- 引导临床决策和改善患者的治疗结果.
主要方法:
- 对接受治疗性手术并出现复发的PDAC患者的回顾性分析.
- 多变量分析以确定复发后生存的显著预后因素.
- 基于已识别的预后因素的存在或不存在的生存时间的比较.
主要成果:
- 红细胞 (RBC) 输血,低白蛋白水平和高碳水化合物抗原19-9 (CA19-9) 水平在复发时是较短生存的显著预测因素.
- 在接受红细胞输血的患者中,中位生存时间明显较低 (5.5 vs 18.1 个月).
- 低的白蛋白 (10.1 vs. 18.7个月) 和高的CA19-9 (11.5 vs. 22.6个月) 也与降低的存活率相关.
结论:
- 红细胞输血,低白蛋白和CA19-9水平升高是复发性PDAC的关键负预后指标.
- 这些因素显著影响疾病复发后的生存时间.
- 临床监测和管理策略应考虑这些生物标志物,以改善患者护理.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
01:30Acute Pancreatitis II: Clinical Manifestations and Management
148
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
148